We identified three distinct Wnt/β-catenin target genes, namely, MYC, MYB, and RUNX1, which showed upregulation in elderly AML compared to the pediatric AML group, thus confirming upregulated Wnt/β-catenin pathway molecules. The gene discussed is RUNX1; the disease is acute myeloid leukemia.